Overview
- 14 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-02-13.
At a glance
Inspections
14
Form 483s
7
EIRs
8
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 2 Feb 2026 – 13 Feb 2026 | Human Drugs | 483 | View 483 → |
| 20 Sep 2021 – 29 Sep 2021 | Human Drugs | 483 | View 483 → |
| 28 Jan 2021 – 3 Feb 2021 | Human Drugs | 483 | On file |
| 1 Apr 2019 – 11 Apr 2019 | Human Drugs | 483 | View 483 → |
| 21 Mar 2018 – 2 Apr 2018 | Human Drugs | Clean | |
| 30 Aug 2016 – 31 Aug 2016 | Human Drugs | Clean | |
| 16 May 2016 – 1 Jun 2016 | Human Drugs | Clean | |
| 27 May 2015 – 5 Jun 2015 | Human Drugs | 483 | View 483 → |
| 5 Jan 2015 – 15 Jan 2015 | Human Drugs | 483 | View 483 → |
| 25 Mar 2013 – 28 Mar 2013 | Human Drugs | Clean | |
| 26 Apr 2012 | Not recorded | Clean | |
| 4 Feb 2011 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigations of discrepancies, failures
Cited by Bryan A Galvez, Sangeeta M Khurana, Joan M Cantellops Figueroa, Cecilia H Kieu, Navneet Kaur, Ana-Maria A Plapcianu, Aranjeet Singh
Equipment construction - reactive surfaces
Cited by Bryan A Galvez, Sangeeta M Khurana, Joan M Cantellops Figueroa, Cecilia H Kieu, Navneet Kaur, Ana-Maria A Plapcianu, Aranjeet Singh
Lab controls established, including changes
Cited by Bryan A Galvez, Amir Alavi, Miguel A Martinez, Claudia M Perez-Kasmarski
In-process sample representation/identification
Cited by Bryan A Galvez, Amir Alavi, Miguel A Martinez, Claudia M Perez-Kasmarski
Laboratory equipment calibration records
Cited by Bryan A Galvez, Amir Alavi, Miguel A Martinez, Claudia M Perez-Kasmarski
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.22(c) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.111 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.182 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(vi) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.65(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Pyramid Laboratories, Inc.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat